Viewing Study NCT00955305

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:28 AM
Ignite Modification Date: 2026-01-24 @ 3:12 AM
Study NCT ID: NCT00955305
Status: TERMINATED
Last Update Posted: 2018-06-06
First Post: 2009-08-07
Is NOT Gene Therapy: True
Has Adverse Events: True
Brief Title: Paclitaxel, Carboplatin, and Bevacizumab With or Without Cixutumumab in Treating Patients With Stage IV or Recurrent Non-small Cell Lung Cancer
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Large Cell Lung Carcinoma View
None Lung Adenocarcinoma View
None Recurrent Non-Small Cell Lung Carcinoma View
None Stage IV Non-Small Cell Lung Cancer View
None Bronchioloalveolar Lung Carcinoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Non-Small Cell Lung Cancer View
None cixutumumab View